USPTO serial 79328112
GENESYSTEM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 24, 2024
- Examiner
- FALK, JONATHAN ROBERT
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GENESYSTEM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael T. Smith
Michael T. Smith BIRCH STEWART KOLASCH & BIRCH, LLP8110 Gatehouse Road, Suite 100EFalls Church, VA 22042United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents for scientific or research use; reagents for scientific or medical research use; reagents for analyzing proteins for scientific or laboratory purposes; reagents for nucleic acid amplifications for scientific or laboratory purposes; reagents for extracting proteins for scientific or laboratory purposes; reagents for analyzing nucleic acid for scientific or laboratory purposes; in vitro diagnostic reagents for scientific purposes; antibody reagents for scientific purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; reagents for nucleic acid amplification other than for medical purposes; biological preparations for use in biotechnology other than medical use; reagents for cell straining other than medical use; reagents for cell transformation other than medical use; reagents for research purposes; chemical reagents for use in genetic research; chemical reagents for genetic identity testing; diagnostic reagents, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; protein synthesis chemical reagent other than for medical purposes; chemical reagent for extracting nucleic acid other than for medical purposes | ACTIVE | — |
| 005 | Reagent paper for veterinary purposes; reagents for use in veterinary genetic testing; veterinary diagnostic reagents; diagnostic agents for pharmaceutical use; diagnostic test reagents for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; diagnostic chemical reagents for medical use; diagnostic reagents for medical or veterinary purposes; immunoassay reagents for medical use; biological reagents for medical purposes; reagents for medical use; reagent paper for medical purposes; reagents for use in medical genetic testing; medical diagnostic reagents; chemical test reagents for medical use; clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes | ACTIVE | — |
| 010 | genetic testing apparatus for medical purposes; genetic testing apparatus for medical purposes for gene verification; miniaturized sensors for use in gene analysis and diagnosis for medical purposes; real-time gene amplification equipment for medical use; medical genetic fragment analyzers; genetic testing apparatus for medical purposes; medical genetic analyzer; biopsy forceps; diagnostic testing apparatus for medical purposes for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; apparatus for taking blood samples; apparatus for DNA and RNA testing for medical purposes; DNA and RNA extraction and purification apparatus for medical purposes; medical immunoassay apparatus for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; medical instruments for application in human bodies, namely, diagnostic kit comprised of medical diagnostic apparatus for testing for viruses, bacteria, fungi, parasite, rickettsia and protista being a pathogen ; medical apparatus for clinical diagnosis for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; clinical diagnostic kit comprised of test chips for the analysis of body fluids, premix mix, nuclease free water, blood sampling tubes and sealing tapes for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; patient medical monitoring instruments for monitoring DNA amplification results; medical instruments, namely, PCR system comprised of, multiplex biochips for analysis of bodily fluids, diagnostic kit comprised of medical diagnostic apparatus for testing for viruses, bacteria, fungi, parasite, rickettsia and protista being a pathogen, PCR reagents; immunoadsorption columns for medical diagnostic use | ACTIVE | — |
| 042 | Research and development of DNA chips; DNA screening for scientific research purposes; DNA analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; DNA testing services to determine paternity being laboratory services; providing information relating to scientific analysis of the genetic information via online networks; biological information check being genetic testing for scientific research purposes; biological information check being genetic testing for medical research purposes; research in the field of gene analysis; genetic fingerprinting being DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; scientific research in the fields of biomedicine; consultancy in analysis of biology sequence processing for medical research purposes; biological research; biochemical research; biotechnological research relating to industry; development of biotechnology; research and development of technology for biotechnology; multiple nucleic acid analysis for scientific research purposes; protein analysis being scientific laboratory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genesystem Co., Ltd.
- Other trademarks owned by Genesystem Co., Ltd.
- Other trademarks owned by Genesystem Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named GENESYSTEM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 22, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 27, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 26, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 24, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 24, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 24, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 19, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 5, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 6, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 6, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 6, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 30, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 11, 2023 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| May 10, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 10, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 20, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 20, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 4, 2023 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 10, 2022 | RFNP | REFUSAL PROCESSED BY IB | — |
| Sep 21, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 20, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 5, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 4, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 2, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 14, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 9, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |